Showing results (61-70 of 104) with videos related to

Sort By:
Pageof 11
Cancer Treatment Reviews|September 10, 2014
Therapeutic options in relapsed or refractory peripheral T-cell lymphomaBertrand Coiffier, Massimo Federico, Dolores Caballero, et al.
British Journal of Sports Medicine|October 13, 2020
Trends in match injury risk in professional male rugby union: a 16-season review of 10 851 match injuries in the English Premiership (2002-2019): the Professional Rugby Injury Surveillance ProjectStephen W West, Lindsay Starling, Simon Kemp, et al.
Antimicrobial Agents and Chemotherapy|October 2, 2013
4-(1H)-Quinolones and 1,2,3,4-Tetrahydroacridin-9(10H)-ones prevent the transmission of Plasmodium falciparum to Anopheles freeborniFabián E Sáenz, Alexis N Lacrue, R Matthew Cross, et al.
Advances in Hematology|December 5, 2009
Outpatient-based therapy of oral fludarabine and subcutaneous alemtuzumab for asian patients with relapsed/refractory chronic lymphocytic leukemiaWilliam Y K Hwang, Claire Dearden, Yvonne S M Loh, et al.
Human Molecular Genetics|February 4, 2010
Fine-scale mapping of the 6p25.3 chronic lymphocytic leukaemia susceptibility locusDalemari Crowther-Swanepoel, Peter Broderick, Yussanne Ma, et al.
Blood|April 22, 2008
Insight into the pathogenesis of chronic lymphocytic leukemia (CLL) through analysis of IgVH gene usage and mutation status in familial CLLDalemari Crowther-Swanepoel, Ruth Wild, Gabrielle Sellick, et al.
Antimicrobial Agents and Chemotherapy|November 7, 2012
4(1H)-Quinolones with liver stage activity against Plasmodium bergheiAlexis N Lacrue, Fabián E Sáenz, R Matthew Cross, et al.
Blood|November 26, 2010
Autologous hematopoietic stem cell transplantation in chronic lymphocytic leukemia: results of European intergroup randomized trial comparing autografting versus observationMauricette Michallet, Peter Dreger, Laurent Sutton, et al.
International Journal of Sports Medicine|February 19, 2021
Padded Headgear does not Reduce the Incidence of Match Concussions in Professional Men's Rugby Union: A Case-control Study of 417 CasesKeith A Stokes, Matthew Cross, Sean Williams, et al.
Future Oncology (London, England)|January 9, 2023
Many People With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Benefit From Ibrutinib Treatment Up To 8 Years: A Plain Language SummaryPaul M Barr, Carolyn Owen, Tadeusz Robak, et al.
Pageof 11